Irene Perlich

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Valerie Pierce, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Irene Perlich:

Company Role Class Num Shares Value Price $ Report Date Ownership
NGM BIOPHARMACEUTICALS INC Principal Accounting Officer Common Stock 0 $0 $1.34 05 Apr 2024 Direct
NGM BIOPHARMACEUTICALS INC Principal Accounting Officer Restricted Stock Unit 0 $0 $1.34 05 Apr 2024 Direct
NGM BIOPHARMACEUTICALS INC Principal Accounting Officer Stock Option (Right to Buy) 0 05 Apr 2024 Direct

Insider Reports Filed by Irene Perlich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024042607-perlich-irene-2024-04-05 NGM BIOPHARMACEUTICALS INC 05 Apr 2024 7 $0 4 Principal Accounting Officer 08 Apr 2024, 16:14
/report/000141588924001543-perlich-irene-2024-01-16 NGM BIOPHARMACEUTICALS INC 16 Jan 2024 1 -$1,374 4 PRINCIPAL ACCOUNTING OFFICER 18 Jan 2024, 18:02
/report/000120919123054734-perlich-irene-2023-11-06 NGM BIOPHARMACEUTICALS INC 06 Nov 2023 6 $0 4 Principal Accounting Officer 08 Nov 2023, 18:11
/report/000120919123049797-perlich-irene-2023-09-15 NGM BIOPHARMACEUTICALS INC 15 Sep 2023 0 $0 3 Principal Accounting Officer 18 Sep 2023, 17:45